Sign up
Log in
12 Health Care Stocks Moving In Tuesday's Pre-Market Session
Share
Listen to the news

Gainers

  • Decoy Therapeutics (NASDAQ:DCOY) shares rose 84.0% to $4.71 during Tuesday's pre-market session. The company's market cap stands at $1.6 million.
  • Greenland Mines (NASDAQ:GRML) shares rose 39.21% to $13.11. The market value of their outstanding shares is at $29.9 million.
  • Viking Therapeutics (NASDAQ:VKTX) shares moved upwards by 38.29% to $41.64. The market value of their outstanding shares is at $3.5 billion.
  • IM Cannabis (NASDAQ:IMCC) shares increased by 36.8% to $4.22. The market value of their outstanding shares is at $1.8 million.
  • FibroBiologics (NASDAQ:FBLG) stock rose 10.29% to $1.5. The company's market cap stands at $9.4 million.
  • Scribe Therapeutics (NASDAQ:SCTX) stock moved upwards by 9.76% to $30.79. The company's market cap stands at $531.0 million.

Losers

  • Silexion Therapeutics (NASDAQ:SLXN) shares decreased by 14.6% to $0.46 during Tuesday's pre-market session. The company's market cap stands at $3.0 million.
  • Celldex Therapeutics (NASDAQ:CLDX) stock decreased by 14.43% to $32.42. The company's market cap stands at $2.9 billion.
  • Creative Medical Tech (NASDAQ:CELZ) stock declined by 11.76% to $0.89. The market value of their outstanding shares is at $6.6 million.
  • Quince Therapeutics (NASDAQ:QNCX) shares declined by 9.94% to $27.92. The company's market cap stands at $31.5 million.
  • Jin Medical International (NASDAQ:ZJYL) shares declined by 7.72% to $1.91. The market value of their outstanding shares is at $16.2 million.
  • Traws Pharma (NASDAQ:TRAW) shares fell 7.37% to $0.46. The company's market cap stands at $7.6 million. See Also: www.benzinga.com/money/best-healthcare-stocks/

This article was generated by Benzinga's automated content engine and reviewed by an editor.

Disclaimer:This article represents the opinion of the author only. It does not represent the opinion of Webull, nor should it be viewed as an indication that Webull either agrees with or confirms the truthfulness or accuracy of the information. It should not be considered as investment advice from Webull or anyone else, nor should it be used as the basis of any investment decision.
What's Trending
No content on the Webull website shall be considered a recommendation or solicitation for the purchase or sale of securities, options or other investment products. All information and data on the website is for reference only and no historical data shall be considered as the basis for judging future trends.